SCHEMBL13667907

SCHEMBL13667907

CCCCOC[C@H]1O[C@@](O)(c2cnc3c(C)nc(SC)nn23)[C@](C)(OCCCC)[C@@H]1OCCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12453964 0.92 — —
SCHEMBL14052074 0.91 KDM4E (0.30) —
SCHEMBL13667909 0.84 — —
SCHEMBL16519881 0.82 — —
SCHEMBL12453973 0.82 — —
SCHEMBL14684661 0.80 — —
SCHEMBL14684679 0.80 — —
SCHEMBL13667495 0.78 — —
SCHEMBL13532542 0.75 — —
SCHEMBL13667815 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009132135-A1 1' -SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT GILEAD SCIENCES, INC. (US) 2009-10-29 — — WO disclosed
Send feedback